Kathy Bergsteinsson

Kathy Bergsteinsson joined Tessera in 2025 as the Chief Financial Officer.  Kathy brings more than 25 years of experience across management, corporate finance, capital markets, M&A, and strategy.  Prior to joining Tessera, Kathy served as Chief Financial Officer at Affini-T Therapeutics.  Previously Kathy worked at Morgan Stanley for 18 years where she served most recently as Managing Director and Head of Healthcare Equity Capital Markets.  She led the healthcare equity capital markets business for over a decade through a period of unprecedented growth, raising over $100bn in equity financing on behalf of her clients to help drive growth and innovation.  During her tenure, she managed over 70 initial public offerings and ~150 follow-on common stock offerings, convertible debt offerings and private placement transactions for clients across all areas of healthcare.  She also worked in the merger and acquisitions department where she advised on approximately $110bn in strategic transactions. Earlier in her career, she worked in various roles in Internet and Technology venture capital and investment banking and in not-for-profit. 

Kathy earned her MBA from The Wharton School at The University of Pennsylvania and her BSE in Industrial Engineering from Stanford University.